Lumea
Chelsea Sowards has an impressive career trajectory in the sales and healthcare industry, holding various titles such as Senior Vice President of Sales, National Sales Director, and Director of Product Development and Strategy. With a background in Business and Marketing from Abilene Christian University, Chelsea has also worked in recruitment roles at MedSynergies and Professional Alternatives. Her previous positions at Inform Diagnostics and Miraca Life Sciences have equipped her with valuable experience in research support, product management, and client services.
Lumea
Lumea is reshaping the pathology landscape with innovative technology solutions that elevate and enhance the entire pathology ecosystem. Since its founding in 2013, Lumea has pioneered one of the first software platforms of its kind, offering a comprehensive suite of products, including proprietary specimen-handling consumables, a digitally-enabled Laboratory Information System (LIS), and a premier IMS/Viewer. Lumea’s unique approach to digital pathology not only increases cancer detection rates but also delivers a substantial return on investment in a cost-sensitive environment and ultimately sets a higher standard of patient care in cancer diagnostics. With over 1.5 million digital diagnoses, Lumea ranks among the top 5 digital pathology platforms for clinical use in the United States. For further insights into the transformative benefits of Lumea technology, visit lumeadigital.com.